138 related articles for article (PubMed ID: 25636897)
1. The rare BRAF VK600-601E mutation as a possible indicator of poor prognosis in rectal carcinoma – a report of a case.
Mori Y; Nagasaka T; Mishima H; Umeda Y; Inada R; Kishimoto H; Goel A; Fujiwara T
BMC Med Genet; 2015 Jan; 16():1. PubMed ID: 25636897
[TBL] [Abstract][Full Text] [Related]
2. The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma.
Kim TY; Kim WB; Rhee YS; Song JY; Kim JM; Gong G; Lee S; Kim SY; Kim SC; Hong SJ; Shong YK
Clin Endocrinol (Oxf); 2006 Sep; 65(3):364-8. PubMed ID: 16918957
[TBL] [Abstract][Full Text] [Related]
3. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K
J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726
[TBL] [Abstract][Full Text] [Related]
4. BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer.
Ilie MI; Long-Mira E; Hofman V; Mouroux J; Vignaud JM; Gauchotte G; Begueret H; Merlio JP; Emile JF; Hébuterne X; Hofman P
Pathology; 2014 Jun; 46(4):311-5. PubMed ID: 24798160
[TBL] [Abstract][Full Text] [Related]
5. Assessment of V600E mutation of BRAF gene and rate of cell proliferation using fine-needle aspirates from metastatic melanomas.
Sviatoha V; Tani E; Ghaderi M; Kleina R; Skoog L
Anticancer Res; 2010 Sep; 30(9):3267-72. PubMed ID: 20944096
[TBL] [Abstract][Full Text] [Related]
6. The BRAF(V600E) mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?
Walczyk A; Kowalska A; Kowalik A; Sygut J; Wypiórkiewicz E; Chodurska R; Pięciak L; Góźdź S
Clin Endocrinol (Oxf); 2014 Jun; 80(6):899-904. PubMed ID: 24354346
[TBL] [Abstract][Full Text] [Related]
7. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis.
Kalady MF; Dejulius KL; Sanchez JA; Jarrar A; Liu X; Manilich E; Skacel M; Church JM
Dis Colon Rectum; 2012 Feb; 55(2):128-33. PubMed ID: 22228154
[TBL] [Abstract][Full Text] [Related]
8. PIK3CA mutations predict local recurrences in rectal cancer patients.
He Y; Van't Veer LJ; Mikolajewska-Hanclich I; van Velthuysen ML; Zeestraten EC; Nagtegaal ID; van de Velde CJ; Marijnen CA
Clin Cancer Res; 2009 Nov; 15(22):6956-62. PubMed ID: 19903786
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes.
Moreau S; Saiag P; Aegerter P; Bosset D; Longvert C; Hélias-Rodzewicz Z; Marin C; Peschaud F; Chagnon S; Zimmermann U; Clerici T; Emile JF
Ann Surg Oncol; 2012 Dec; 19(13):4314-21. PubMed ID: 22772867
[TBL] [Abstract][Full Text] [Related]
10. BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy.
Barbour AP; Tang YH; Armour N; Dutton-Regester K; Krause L; Loffler KA; Lambie D; Burmeister B; Thomas J; Smithers BM; Hayward NK
Eur J Cancer; 2014 Oct; 50(15):2668-76. PubMed ID: 25070294
[TBL] [Abstract][Full Text] [Related]
11. Breast metastasis from rectal cancer with BRAF V600E mutation: a case report with a review of the literature.
Hasegawa H; Nagata Y; Sakakibara Y; Miyake M; Mori K; Masuda N; Mano M; Nakazuru S; Ishida H; Mita E
Clin J Gastroenterol; 2020 Apr; 13(2):153-157. PubMed ID: 31482523
[TBL] [Abstract][Full Text] [Related]
12. The genetic alterations of rectal neuroendocrine tumor and indications for therapy and prognosis: a systematic review.
Li K; Liu Y; Han J; Gui J; Zhang X
Endocr J; 2023 Feb; 70(2):197-205. PubMed ID: 36403965
[TBL] [Abstract][Full Text] [Related]
13. Triple-Regimen of Vemurafenib, Irinotecan, and Cetuximab for the Treatment of BRAF
Cho SM; Esmail A; Abdelrahim M
Front Pharmacol; 2021; 12():795381. PubMed ID: 34975492
[TBL] [Abstract][Full Text] [Related]
14. The Role of Dynamic ctDNA Monitoring During Combination Therapies of BRAF V600E-Mutated Metastatic Colorectal Cancer: A Case Report.
Wang Z; Ye CY; Zhou WL; Wang MM; Dai WP; Zheng J; Zang YS
Onco Targets Ther; 2020; 13():11849-11853. PubMed ID: 33235471
[TBL] [Abstract][Full Text] [Related]
15. BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report.
Moisset L; Raimbourg J; Hiret S; Dauve J; Boisdron-Celle M; Senellart H; Raoul JL
Case Rep Oncol; 2019; 12(2):426-429. PubMed ID: 31244646
[TBL] [Abstract][Full Text] [Related]
16. Rhabdoid carcinoma of the rectum.
Samalavicius NE; Stulpinas R; Gasilionis V; Baltruskeviciene E; Aleknavicius E; Mickys U
Ann Coloproctol; 2013 Dec; 29(6):252-5. PubMed ID: 24466541
[TBL] [Abstract][Full Text] [Related]
17. Non-small Cell Lung Cancer With Proto-Oncogene B-Raf V600E Presenting a Distinctive Clinical Course: A Case Report.
Sasada A; Yuba T; Shiotsu S; Tsuji T; Hiraoka N
Cureus; 2022 Mar; 14(3):e23055. PubMed ID: 35464513
[TBL] [Abstract][Full Text] [Related]
18. A Case Report: Cutaneous Metastasis of Advanced Rectal Cancer with BRAF Mutation.
Zhou S; Tang W; Wang Q; Zhang X; Jin X; Xu X; Fu J
Onco Targets Ther; 2021; 14():989-993. PubMed ID: 33603403
[TBL] [Abstract][Full Text] [Related]
19. AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain Mutants.
Hechtman JF; Sadowska J; Huse JT; Borsu L; Yaeger R; Shia J; Vakiani E; Ladanyi M; Arcila ME
Mol Cancer Res; 2015 Jun; 13(6):1003-8. PubMed ID: 25714871
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis.
Baba K; Oshita A; Kohyama M; Inoue S; Kuroo Y; Yamaguchi T; Nakamura H; Sugiyama Y; Tazaki T; Sasaki M; Imamura Y; Daimaru Y; Ohdan H; Nakamitsu A
World J Gastroenterol; 2015 Feb; 21(6):1982-8. PubMed ID: 25684967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
